TAT-D1 Peptide

(HB9975)

Certificate of Analysis

Latest Certificate of Analysis

Download the latest CoA for this product:

Download CoA

Download Batch-Specific CoA

To download the CoA for a batch, enter the batch ID below:

Technical documents: CoA Datasheet

Product overview

Name TAT-D1 Peptide
Purity >95%
Description Selective D1-D2 heteromer antagonist
Write Your Own Review
You're reviewing:TAT-D1 Peptide
Rate this item:

Biological Data

Biological description Selective Dopamine D1-D2 heteromer antagonist which occludes the interaction site between the two receptors to inhibit D1-D2 heteromer expression and function. Alleviates behavioural despair symptoms and exerts antidepressant-like effects. Active in vivo.

Solubility & Handling

Solubility overview Soluble in PBS (1 mg/ml), and in DMSO
Storage instructions -20°C
Storage of solutions Prepare and use solutions on the same day if possible. Store solutions at -20°C for up to one month if storage is required. Equilibrate to RT and ensure the solution is precipitate free before use.
Shipping Conditions Stable for ambient temperature shipping. Follow storage instructions on receipt.
Important This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use.

Calculators

Molarity

=
x
x
More Info

Dilution

x
=
x
More Info

Chemical Data

Purity >95%
Molecular Weight 3472.97
Molecular Formula C144H257N57O43

References for TAT-D1 Peptide

References are publications that support the biological activity of the product
  • Mitochondria-derived peptide SHLP2 regulates energy homeostasis through the activation of hypothalamic neurons.

    Kim SK et al (2023) Nature communications 14 : 4321
  • Effects of Mitochondrial-Derived Peptides (MDPs) on Mitochondrial and Cellular Health in AMD.

    Nashine S et al (2020) Cells 9 :
  • Modulation and functions of dopamine receptor heteromers in drugs of abuse-induced adaptations.

    Andrianarivelo A et al (2019) Neuropharmacology 152 : 42-50
  • The dopamine D1-D2 receptor heteromer exerts a tonic inhibitory effect on the expression of amphetamine-induced locomotor sensitization.

    Shen MY et al (2015) Pharmacology, biochemistry, and behavior 128 : 33-40
  • A peptide targeting an interaction interface disrupts the dopamine D1-D2 receptor heteromer to block signaling and function in vitro and in vivo: effective selective antagonism.

    Hasbi A et al (2014) FASEB journal : official publication of the Federation of American Societies for Experimental Biology 28 : 4806-20

5 Item(s)